Loading...

ADC Therapeutics SA (NYSE:ADCT)

7.89 USD +1.01 USD ( +14.68% )
Watchlist Manager
ADC Therapeutics SA
NYSE:ADCT
Watchlist

P/E
Price to Earnings

The Price to Earnings (P/E) ratio is a valuation multiple that compares a company’s market capitalization to its net income. It indicates the dollar amount an investor can expect to invest in a company in order to receive $1 of that company’s earnings.

P/E
=
Market Cap
/
Net Income
Current P/E
ADCT
-3.1
Median P/E
ADCT
N/A
Industry P/E
Biotechnology
4.7

P/E History

Statistics
Price to Earnings

1 Year 3 Years 5 Years
Average -7 -3.6 -2.2
Median -6.7 N/A N/A
Min -11.2 N/A N/A
Max -2.6 -2.6 -2.6

History Chart
Price to Earnings

P/E Forward Multiples

Forward P/E multiple is a version of the P/E ratio that uses forecasted net income for the P/E calculation. 1-Year, 2-Years, and 3-Years forwards use net income forecasts for 1, 2, and 3 years ahead, respectively.

1-Year Forward
P/E
-3
2-Years Forward
P/E
-2.6
3-Years Forward
P/E
-3.4

P/E Across Competitors

ADCT Competitors
ADC Therapeutics SA Competitors

Country Company Market Cap P/E
CH
ADC Therapeutics SA
NYSE:ADCT
606M USD N/A
US
Abbvie Inc
NYSE:ABBV
269B USD 21.6
US
Amgen Inc
NASDAQ:AMGN
131B USD 22.9
AU
CSL Ltd
ASX:CSL
128B AUD 38.2
US
Gilead Sciences Inc
NASDAQ:GILD
79.2B USD 17.5
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
74.8B USD 30.5

Relative Valuation Report

View full relative valuation report for ADC Therapeutics SA, which takes into account all ADCT`s valuation multiples.

See Also

Similar Stocks